Side-by-side comparison of AI visibility scores, market position, and capabilities
ZOE is a health science company using large-scale nutritional studies (PREDICT), microbiome sequencing, and AI to deliver personalized nutrition programs; co-founded by scientist Tim Spector and Christopher Gardner; raised $115M+ total;
ZOE is a health science and consumer technology company headquartered in London, United Kingdom, co-founded by Professor Tim Spector (King's College London epidemiologist and author), Jonathan Wolf, and others. The company emerged from the PREDICT studies — the world's largest nutritional science research program, which enrolled over 1,000 participants to study how different individuals respond to the same foods based on their gut microbiome, blood fat response, blood sugar response, sleep, and exercise patterns. The research established that personalized nutrition — rather than one-size-fits-all dietary guidelines — is scientifically grounded, as the same meal can produce dramatically different metabolic responses in different people.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.